GA not only blocks the HERG channel, IK (IKr, IKs), but also inhibits INa, so the results reveal that it has significant potential for development as a novel antiarrhythmic agent, particularly targeting the genesis of arrhythmias. Here, INA is linked to cardiac arrhythmia.